Analyst Ratings (USA)
Today’s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction. Analysts continue to support long-term growth themes in areas like semiconductors, AI infrastructure, biotech, and high-quality industrials, where price targets are being meaningfully raised (in some cases aggressively).
At the same time, there is a noticeable increase in downgrades,especially in cyclicals, consumer exposure, and certain software names. These moves generally reflect valuation sensitivity, slowing growth normalization, or reduced near-term catalysts rather than outright deterioration in fundamentals.
The key takeaway is that analysts are not uniformly bearish or bullish, instead they are becoming more selective and rewarding companies with clear earnings momentum and penalizing those where expectations appear ahead of fundamentals. This typically indicates a late-cycle or re-pricing environment where stock-specific execution matters more than broad sector exposure.
131 Analyst Updates
3M (MMM) — Goldman Sachs upgraded 3M and reiterated a Buy rating with a $190 price target.
Absci (ABSI) — Guggenheim raised its price target to $15.00 from $10.00 and maintained a Buy rating.
Acadia Realty Trust (AKR) — KeyCorp reiterated its Sector Weight rating.
Accenture (ACN) — Jefferies Financial Group lowered its price target to $185.00 from $210.00 and maintained a Hold rating.
Accenture (ACN) — Morgan Stanley downgraded Accenture to Equal Weight from Overweight and lowered its price target to $177.00 from $240.00.
Acerinox (ANIOY) — Morgan Stanley reiterated its Overweight rating on Acerinox.
Adecoagro (AGRO) — JPMorgan Chase & Co. raised its price target to $10.50 from $7.00 and maintained an Underweight rating.
Advanced Micro Devices (AMD) — Wolfe Research initiated coverage with an Outperform rating and a $450.00 price target.
American Homes 4 Rent (AMH) — BMO Capital Markets raised its price target to $39.00 from $36.00 and maintained a Market Perform rating.
AMETEK (AME) — Citigroup initiated coverage of AMETEK with a Neutral rating and a $257.00 price target.
Andersons (ANDE) — Benchmark reiterated its Buy rating on Andersons.
AON (AON) — Piper Sandler lowered its price target to $355.00 from $360.00 and maintained an Overweight rating.
ArcBest (ARCB) — Citigroup raised its price target to $202.00 from $150.00 and maintained a Buy rating.
Archer Daniels Midland (ADM) — UBS raised its price target to $95.00 from $90.00 and maintained a Buy rating.
ASML (ASML) — Sanford C. Bernstein reiterated its Buy rating on ASML.
Assa Abloy (ASAZY) — Barclays reiterated its Overweight rating on Assa Abloy.
Assembly Biosciences (ASMB) — Mizuho raised its price target to $45.00 from $40.00 and maintained an Outperform rating.
Autoliv (ALV) — UBS raised its price target to $122.00 from $110.00 and maintained a Neutral rating.
Aviat Networks (AVNW) — Citigroup upgraded Aviat Networks to an Outperform rating.
Aviat Networks (AVNW) — Northland Securities upgraded Aviat Networks to Outperform from Market Perform and raised its price target to $25.00 from $20.00.
Avista (AVA) — Barclays lowered its price target to $39.00 from $42.00 and maintained an Equal Weight rating.
Axon Enterprise (AXON) — Piper Sandler reiterated its Overweight rating and set a $674.00 price target.
Baldwin Insurance Group (BWIN) — TD Cowen reiterated its Buy rating on Baldwin Insurance Group.
Belite Bio (BLTE) — HC Wainwright reiterated its Buy rating and maintained a $200.00 price target.
Better Home & Finance (BETR) — Roth MKM initiated coverage of Better Home & Finance with a Buy rating and a $35.00 price target.
Biodesix (BDSX) — HC Wainwright initiated coverage of Biodesix with a Buy rating and a $26.00 price target.
Biogen (BIIB) — Mizuho lowered its price target to $221.00 from $236.00 and maintained an Outperform rating.
Braemar Hotels & Resorts (BHR) — Robert W. Baird lowered its price target to $2.00 from $3.50 and maintained a Neutral rating.
Braiin (BRAI) — Maxim Group initiated coverage of Braiin with a Buy rating and a $10.00 price target.
BrainsWay (BWAY) — HC Wainwright reiterated its Buy rating and maintained a $17.00 price target.
Braze (BRZE) — TD Cowen reiterated its Buy rating on Braze.
Brixmor Property Group (BRX) — BMO Capital Markets raised its price target to $37.00 from $35.00 and maintained an Outperform rating.
Brookdale Senior Living (BKD) — Compass Point initiated coverage of Brookdale Senior Living with a Buy rating and a $22.00 price target.
C.H. Robinson Worldwide (CHRW) — Citigroup downgraded C.H. Robinson Worldwide to Neutral from Buy and set a $199.00 price target.
CACI International (CACI) — JPMorgan lowered its price target to $645.00 from $700.00 and maintained an Overweight rating.
Caesars Entertainment (CZR) — Stifel downgraded Caesars Entertainment to Hold from Buy and set a $31.00 price target.
Calian Group (CGY) — Ventum raised its price target to C$100.00 from C$94.00 and maintained a Buy rating.
Cameco (CCJ) — Sanford C. Bernstein reiterated its Outperform rating and maintained a $135.00 price target.
Canadian Pacific Kansas City (CP) — BMO Capital Markets raised its price target to C$142.00 from C$132.00 and maintained an Outperform rating.
Canadian Solar (CSIQ) — Mizuho raised its price target to $18.00 from $15.00 and maintained a Neutral rating.
Capstone Copper (CS) — Scotiabank raised its price target to C$18.00 from C$15.50 and maintained a Sector Outperform rating.
Cardinal Infrastructure Group (CDNL) — Oppenheimer raised its price target to $80.00 from $60.00 and maintained an Outperform rating.
CareTrust REIT (CTRE) — BMO Capital Markets raised its price target to $47.00 from $46.00 and maintained an Outperform rating.
Casey’s General Stores (CASY) — Deutsche Bank reiterated its Buy rating and maintained a $1,000.00 price target.
Celldex Therapeutics (CLDX) — HC Wainwright reiterated its Buy rating and maintained a $42.00 price target.
Ceva (CEVA) — Needham initiated coverage with a Buy rating and a $55.00 price target.
CF Industries (CF) — BNP Paribas Exane lowered its price target to $120.00 from $140.00 and maintained a Neutral rating.
Champion Iron (CIA) — Scotiabank lowered its price target to C$5.50 from C$6.00 and maintained a Sector Outperform rating.
Cheesecake Factory (CAKE) — Citigroup downgraded Cheesecake Factory to Neutral from Buy.
Cheesecake Factory (CAKE) — Northcoast Research downgraded Cheesecake Factory to Neutral from Buy.
Chugai Pharmaceutical (CHGCY) — Goldman Sachs upgraded Chugai Pharmaceutical to a Buy rating.
Cintas (CTAS) — Truist Financial lowered its price target to $225.00 from $255.00 and maintained a Buy rating.
Citizens Financial Group (CFG) — Stephens initiated coverage with an Equal Weight rating.
Citizens Holding (CIZN) — UBS set a $30.00 price target on Citizens Holding.
Cloudflare (NET) — Citi, New Street, and Citizens JMP all reiterated Market Outperform ratings, with JMP setting a $270 target.
CME Group (CME) — Piper Sandler reiterated its Overweight rating and maintained a $329.00 price target.
CME Group (CME) — UBS reiterated its Overweight rating on CME Group.
Columbus McKinnon (CMCO) — DA Davidson lowered its price target to $17.00 from $20.00 and maintained a Neutral rating.
Corporacion America Airports (CAAP) — JPMorgan raised its price target to $33.00 from $30.00 and maintained an Overweight rating.
Coupang (CPNG) — CLSA initiated coverage with an Outperform rating and a $24.00 price target.
Cracker Barrel Old Country Store (CBRL) — BofA raised its price target to $40.00 from $34.00.
Credicorp (BAP) — JPMorgan downgraded Credicorp to Neutral from Overweight and set a $415.00 price target.
Crinetics Pharmaceuticals (CRNX) — HC Wainwright reiterated its Buy rating and maintained a $81.00 price target.
Crocs (CROX) — Stifel raised its price target to $125.00 from $105.00 and maintained a Hold rating.
CSX (CSX) — Royal Bank of Canada reiterated its Outperform rating on CSX.
Curbline Properties (CURB) — Wolfe Research downgraded Curbline Properties to Peer Perform from Outperform.
D-Wave Quantum (QBTS) — Mizuho raised its price target to $35 from $29 and maintained an Outperform rating.
Darden Restaurants (DRI) — Citigroup raised its price target to $245.00 from $238.00 and maintained a Buy rating.
Datadog (DDOG) — Citigroup downgraded Datadog to Neutral from Outperform.
Datadog (DDOG) — Craig-Hallum initiated coverage with a Buy rating.
Datadog (DDOG) — Jefferies upgraded Datadog to a Buy rating.
Datadog (DDOG) — KeyCorp upgraded Datadog to an Overweight rating.
Datadog (DDOG) — Morgan Stanley upgraded Datadog to an Overweight rating.
Datadog (DDOG) — Needham initiated coverage with a Buy rating.
Datadog (DDOG) — Truist Financial upgraded Datadog to Buy from Hold and raised its price target to $300.00 from $190.00.
Datadog (DDOG) — Wedbush changed its rating on Datadog to Neutral from Outperform.
Devon Energy (DVN) — Raymond James lowered its price target to $66.00 from $72.00 and maintained a Strong Buy rating.
DexCom (DXCM) — Piper Sandler reiterated its Overweight rating and raised its price target to $88.00 from $75.00.
Dolby Laboratories (DLB) — Barrington Research reiterated its Outperform rating and maintained a $90.00 price target.
DTE Energy (DTE) — Wells Fargo reiterated its Overweight rating and maintained a $165.00 price target.
Duos Technologies Group (DUOT) — Ascendiant Capital Markets raised its price target to $22.00 from $17.00 and maintained a Buy rating.
DuPont de Nemours (DD) — Goldman Sachs initiated coverage with a Neutral rating and a $53.00 price target.
EchoStar (SATS) — New Street Research set a price target of $165 on EchoStar.
Eli Lilly (LLY) — BMO reiterated an Outperform rating on Eli Lilly.
Elicio Therapeutics (ELTX) — HC Wainwright raised its price target to $23 from $17 and maintained a Buy rating, while Rodman & Renshaw also reiterated a Buy rating.
EPAM Systems (EPAM) — Wedbush initiated coverage with a Neutral (Sector Perform) rating and a $99 price target.
Ero Copper (ERO) — Scotiabank reiterated an Outperform rating and raised its price target to C$55 from C$50.
ESCO Technologies (ESE) — JPMorgan initiated coverage with an Overweight rating and a $420 price target.
Exodus Movement (EXOD) — Cantor Fitzgerald reiterated an Overweight rating on Exodus Movement.
Extreme Networks (EXTR) — Lake Street Capital raised its price target to $34 from $25 and maintained a Buy rating.
ExxonMobil (XOM) — TD Cowen reiterated a Buy rating on ExxonMobil.
Ferrari (RACE) — Morgan Stanley upgraded Ferrari to Overweight from Equal Weight and raised its price target to $438 from $388.
Fifth Third Bancorp (FITB) — Stephens initiated coverage with an Equal Weight rating and a $58 price target.
Firefly Aerospace (FLY) — KeyCorp upgraded Firefly Aerospace to Overweight from Sector Weight and set a $50 price target.
Fox Corporation (FOXA) — UBS reiterated a Neutral rating, while Barclays lowered its price target to $60 from $67 and maintained an Equal Weight rating.
Freeport-McMoRan (FCX) — Scotiabank raised its price target to $77 from $67 and maintained a Sector Outperform rating.
Full Truck Alliance (YMM) — Nomura set an $11 price target on Full Truck Alliance.
Globus Maritime (GLBS) — Maxim Group raised its price target to $5 from $3 and maintained a Buy rating.
Globus Medical (GMED) — Piper Sandler lowered its price target to $100 from $115 while maintaining an Overweight rating.
Grupo Mexico (GMBXF) — Scotiabank reiterated a Sector Perform rating.
Haemonetics (HAE) — Mizuho raised its price target to $85 from $70 and maintained an Outperform rating.
Halma (HLMAF) — BNP Paribas Exane upgraded Halma to Outperform.
Harley-Davidson (HOG) — Wolfe Research reiterated an Outperform rating on Harley-Davidson.
Harmonic (HLIT) — Rosenblatt reiterated a Buy rating with a $20 price target.
HawkEye 360 (HAWK) — Jefferies upgraded HawkEye 360 to Buy from Hold with a $34 price target.
Healthpeak Properties (DOC) — BMO Capital Markets raised its price target to $24 from $20 and maintained an Outperform rating.
Hilton Worldwide (HLT) — Argus raised its price target to $400 from $380 and maintained a Buy rating.
Hinge Health (HNGE) — Canaccord raised its price target to $76 from $65, and Raymond James raised its target to $80 from $70, both maintaining positive ratings.
Hudson Pacific Properties (HPP) — BMO raised its price target to $16 from $8 and maintained a Market Perform rating.
Humana (HUM) — UBS reiterated a Neutral rating on Humana.
Huntington Bancshares (HBAN) — Stephens initiated coverage with an Equal Weight rating and a $19 price target.
ICU Medical (ICUI) — BTIG initiated coverage with a Buy rating and a $170 price target, while Bernstein downgraded the stock to Market Perform.
Incyte (INCY) — BMO reiterated an Underperform rating on Incyte.
Innodata (INOD) — BWS Financial reiterated a Buy rating, raised its price target to $140 from $110, and named it a Top Pick.
Inspire Medical Systems (INSP) — Royal Bank of Canada downgraded the stock to Buy from Sector Perform.
Inspire Medical Systems (INSP) — Oppenheimer reiterated a Market Perform rating.
Intellia Therapeutics (NTLA) — Citizens JMP reiterated a Outperform rating with a $30 price target.
Intellia Therapeutics (NTLA) — Wedbush reiterated a Neutral rating with a $12 price target.
Intellia Therapeutics (NTLA) — Citigroup reiterated a Outperform rating (no price target provided).
Intellia Therapeutics (NTLA) — HC Wainwright reiterated a Buy rating with a $25 price target.
Intellia Therapeutics (NTLA) — New Street Research set a $25 price target.
Intercorp Financial Services (IFS) — JPMorgan downgraded the stock to Neutral from Overweight with a $56 price target.
Invitation Homes (INVH) — BMO raised its price target to $35 from $32 and maintained a Market Perform rating.
Invivyd (IVVD) — HC Wainwright reiterated a Buy rating with a $10 price target.
Ionis Pharmaceuticals (IONS) — TD Cowen reiterated a Buy rating with a $108 price target.
Ivanhoe Mines (IVN) — Scotiabank raised its price target to C$13.50 from C$13.00 and maintained a Sector Perform rating.
Jabil (JBL) — Stifel raised its price target to $430 from $290 and maintained a Buy rating.
Jade Biosciences (JBIO) — UBS initiated coverage with a Buy rating and a $45 price target.
Jeronimo Martins (JRONY) — Citigroup reiterated a Buy rating.
Kalaris Therapeutics (KLRS) — TD Cowen initiated coverage with a Buy rating.
KeyCorp (KEY) — Stephens initiated coverage with an Overweight rating and a $26 price target.
Kilroy Realty (KRC) — BMO raised its price target to $38 from $34 and maintained a Market Perform rating.
Kinder Morgan (KMI) — UBS reiterated a Buy rating with a $43 price target.
Knight-Swift Transportation (KNX) — Citi downgraded the stock to Neutral from Buy and set a $90 price target.
Knightscope (KSCP) — Ascendiant Capital Markets lowered its price target to $23 from $26 and maintained a Buy rating.
Kodiak AI (KDK) — Craig Hallum initiated coverage with a Buy rating and a $12 price target.
Kura Oncology (KURA) — Citizens JMP and Sanford Bernstein both reiterated positive ratings with a $24 price target.
Lam Research (LRCX) — Oppenheimer raised its price target to $400 from $330 and maintained an Outperform rating.
Lennar (LEN) — BTIG set a price target of $67 with no rating change specified.
Lennar (LEN) — Wells Fargo lowered its price target to $85 from $90 and maintained an Equal Weight rating.
Lennar (LEN) — Royal Bank of Canada lowered its price target to $85 from $88 and maintained an Underperform rating.
Lennar (LEN) — Evercore raised its price target to $87 from $82 but maintained an Underperform rating.
Lennar (LEN) — Barclays lowered its price target to $79 from $80 and maintained an Underweight rating.
Life Time Group (LTH) — Guggenheim raised its price target to $41 from $36 and maintained a Buy rating.
Lifeway Foods (LWAY) — Benchmark reiterated a Buy rating.
Lundin Mining (LUNMF) — Scotiabank reiterated an Outperform rating.
Lyell Immunopharma (LYEL) — Needham and Citizens JMP both reiterated Buy and Market Outperform ratings with targets between $34 and $44.
Malibu Boats (MBUU) — DA Davidson reiterated a Neutral rating with a $30 price target.
Marathon Petroleum (MPC) — Wells Fargo reiterated an Overweight rating with a $344 price target.
Marriott International (MAR) — UBS raised its price target to $412 from $336, while Bernstein also set a $412 target.
MGM Resorts (MGM) — UBS set a $49 price target, while Stifel downgraded the stock to Hold.
Micron Technology (MU) — RBC and TD Cowen both significantly raised price targets to $1,200–$1,500 respectively, while maintaining bullish ratings.
Mirum Pharmaceuticals (MIRM) — Citizens JMP raised its price target to $146 from $140 and maintained a Market Outperform rating.
Mirum Pharmaceuticals (MIRM) — CLSA set a $146 price target with no rating change specified.
Mirum Pharmaceuticals (MIRM) — Citi reiterated an Outperform rating.
Mirum Pharmaceuticals (MIRM) — HC Wainwright reiterated a Buy rating.
Mosaic (MOS) — BNP Paribas Exane lowered its price target to $29 from $30.
National Health Investors (NHI) — BMO lowered its price target to $80 from $90 while maintaining an Outperform rating.
Nexa Resources (NEXA) — Scotiabank slightly raised its price target to $14.50 from $14.
Northern Oil and Gas (NOG) — Raymond James lowered its price target to $30 from $35.
Northrop Grumman (NOC) — Raymond James reiterated an Outperform rating.
Nurix Therapeutics (NRIX) — Needham reiterated a Buy rating with a $34 price target.
Old Dominion Freight Line (ODFL) — Citi downgraded the stock to Sell.
Ollie’s Bargain Outlet (OLLI) — KeyCorp reiterated an Overweight rating.
Omega Healthcare Investors (OHI) — Citi reiterated a Market Perform rating.
Onsemi (ON) — Citi raised its price target to $120 from $100.
Opus Genetics (IRD) — Citizens JMP reiterated a Market Outperform rating with an $11 price target.
OrthoPediatrics (KIDS) — TD Cowen reiterated a Buy rating.
Paychex (PAYX) — Citi upgraded the stock to Buy and raised its price target to $140 from $99.
Payoneer Global (PAYO) — Needham downgraded the stock to Hold.
Peloton (PTON) — UBS reiterated a Buy rating.
Phillips 66 (PSX) — UBS reiterated a Buy rating with a $212 price target.
Piedmont Realty Trust (PDM) — Truist reiterated a Buy rating.
Pinterest (PINS) — Guggenheim reiterated a Buy rating.
Planet Labs PBC (PL) — Deutsche Bank reiterated a Buy rating with a $36 price target.
PNC Financial (PNC) — Stephens initiated coverage with an Overweight rating and a $265 price target.
PPG Industries (PPG) — BMO raised its price target to $140 from $135 and maintained an Outperform rating.
Primoris Services (PRIM) — Wolfe Research reiterated an Outperform rating with a $149 price target.
Public Storage (PSA) — BMO raised its price target to $340 from $305.
Quantum Computing Inc. (QUBT) — Ascendiant raised its price target to $30 from $27 and maintained a Buy rating.
Regions Financial (RF) — Stephens initiated coverage with an Equal Weight rating.
ResMed (RMD) — Citi lowered its price target to $270 and maintained a Buy rating.
Rezolute (RZLT) — Guggenheim raised its price target to $11 from $6 and maintained a Buy rating.
RH (RH) — Citi raised its price target to $166 from $150 and maintained a Neutral rating.
Rhythm Pharmaceuticals (RYTM) — Wells Fargo raised its price target to $155 from $144 and maintained an Overweight rating.
Rivian Automotive (RIVN) — Cantor Fitzgerald reiterated a Neutral rating.
Rocket Lab (RKLB) — KeyCorp upgraded the stock to Overweight with a $135 price target.
Rogers Corp (ROG) — B. Riley raised its price target to $200 from $155 and maintained a Buy rating.
Roku (ROKU) — Citizens JMP raised its price target to $175 from $170 and maintained a Market Outperform rating.
Roku (ROKU) — Needham raised its price target to $170 from $140 and maintained a Buy rating.
Roku (ROKU) — Citi reiterated an Outperform rating.
Roku (ROKU) — Robert W. Baird downgraded Roku to Neutral from Outperform and set a $160 price target.
Roku (ROKU) — William Blair downgraded Roku to Market Perform from Outperform.
Roku (ROKU) — Oppenheimer downgraded Roku to Market Perform from Outperform.
Roku (ROKU) — Jefferies downgraded Roku to Hold from Buy and set a $160 price target.
Roku (ROKU) — KeyCorp downgraded Roku to Sector Weight from Overweight.
Runway Growth Finance (RWAY) — BofA downgraded the stock to Underperform.
SAB Biotherapeutics (SABS) — HC Wainwright reiterated a Buy rating with a $10 price target, while Leerink raised its target to $12.
Safestore (SFSHF) — Morgan Stanley maintained an Underweight rating.
Saia (SAIA) — Citi downgraded the stock to Neutral.
Salesforce (CRM) — Wolfe Research reiterated an Outperform rating.
Sasol (SSL) — JPMorgan downgraded the stock to Neutral.
Satellogic (SATL) — Cantor Fitzgerald reiterated an Overweight rating.
Seagate Technology (STX) — Morgan Stanley raised its price target to $1,035 from $767 and maintained an Overweight rating.
ServiceNow (NOW) — Cantor Fitzgerald and Benchmark both maintained positive outlooks with $130 price targets.
Silvercorp Metals (SVM) — Roth MKM and Jefferies both upgraded the stock to Buy.
SoftwareOne (SWONF) — BNP Paribas upgraded the stock to Outperform.
Sonos (SONO) — Rosenblatt reiterated a Buy rating with a $21 price target.
SOPHiA GENETICS (SOPH) — BTIG reiterated a Buy rating with an $8 price target.
Southern Copper (SCCO) — Scotiabank maintained an Underperform stance but slightly raised its price target to $140.
Strategy Inc (MSTR) — Cantor Fitzgerald reiterated an Overweight rating.
Stride (LRN) — BMO maintained a Market Perform rating.
Strive (ASST) — Benchmark reiterated a Buy rating.
Take-Two Interactive (TTWO) — DA Davidson reiterated a Buy rating with a $300 price target.
Tanger (SKT) — BMO raised its price target to $42 from $40 and maintained a Market Perform rating.
Target (TGT) — Bernstein reiterated a Market Perform rating.
TE Connectivity (TEL) — Barclays raised its price target to $300 and maintained an Overweight rating.
Teck Resources (TECK) — Scotiabank maintained a Sector Perform rating.
TeraWulf (WULF) — Bank of America initiated coverage with a Buy rating and a $34 price target.
Tesla (TSLA) — HSBC maintained a Hold rating.
Texas Instruments (TXN) — Citi raised its price target to $345 and maintained a Buy rating.
TFI International (TFII) — Citi raised its price target to $188 and maintained a Buy rating.
Thor Industries (THO) — DA Davidson maintained a Neutral rating with an $80 price target.
TransDigm (TDG) — JPMorgan raised its price target to $1,450 and maintained a Neutral rating.
Travere Therapeutics (TVTX) — Citi raised its price target to $70 and maintained a Buy rating.
TripAdvisor (TRIP) — DA Davidson maintained a Neutral rating, while BTIG maintained a Buy rating.
Truist Financial (TFC) — Stephens initiated coverage with an Overweight rating and a $59 price target.
Twist Bioscience (TWST) — TD Cowen raised its price target to $89 from $68 and maintained a Buy rating.
Twist Bioscience (TWST) — UBS set a price target of $89 with no rating change specified.
Twist Bioscience (TWST) — Canaccord Genuity initiated coverage with a Buy rating and a $90 price target.
U.S. Bancorp (USB) — Stephens initiated coverage with an Equal Weight rating.
United Community Banks (UCB) — DA Davidson raised its price target to $40 and maintained a Buy rating.
United Parks & Resorts (PRKS) — UBS maintained a Neutral rating.
Upstart (UPST) — Needham reiterated a Buy rating with a $37 price target.
Vale (VALE) — Scotiabank and RBC maintained neutral/sector perform ratings.
VEON (VEON) — Benchmark reiterated a Buy rating.
Vornado Realty Trust (VNO) — BMO raised its price target to $43 and maintained an Outperform rating.
Welltower (WELL) — RBC reiterated an Outperform rating with a $238 price target.
Western Digital (WDC) — Morgan Stanley raised its price target to $650 and maintained an Overweight rating.
Winnebago Industries (WGO) — DA Davidson maintained a Neutral rating.
Wix.com (WIX) — Needham maintained a Buy rating with an $80 price target.
XPO (XPO) — Citi raised its price target to $236 and maintained a Neutral rating.
Zions Bancorporation (ZION) — Stephens initiated coverage with an Overweight rating and a $79 price target.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
